Protective Efficacy of the OprF/OprI/PcrV Recombinant Chimeric Protein Against Pseudomonas aeruginosa in the Burned BALB/c Mouse Model

Mohammad Hadi Fakoor,1 Seyed Latif Mousavi Gargari,2 Parviz Owlia,3 Azar Sabokbar1 1Department of Microbiology, Karaj Branch, Islamic Azad University, Karaj, Iran; 2Department of Biology, Faculty of Basic Sciences, Shahed University, Tehran, Iran; 3Molecular Microbiology Research Center, Shahed Univ...

Full description

Bibliographic Details
Main Authors: Fakoor MH, Mousavi Gargari SL, Owlia P, Sabokbar A
Format: Article
Language:English
Published: Dove Medical Press 2020-06-01
Series:Infection and Drug Resistance
Subjects:
Online Access:https://www.dovepress.com/protective-efficacy-of-the-oprfopripcrv-recombinant-chimeric-protein-a-peer-reviewed-article-IDR
id doaj-38b486b0ea394158888acfbf230aaafd
record_format Article
spelling doaj-38b486b0ea394158888acfbf230aaafd2020-11-25T03:20:14ZengDove Medical PressInfection and Drug Resistance1178-69732020-06-01Volume 131651166154351Protective Efficacy of the OprF/OprI/PcrV Recombinant Chimeric Protein Against Pseudomonas aeruginosa in the Burned BALB/c Mouse ModelFakoor MHMousavi Gargari SLOwlia PSabokbar AMohammad Hadi Fakoor,1 Seyed Latif Mousavi Gargari,2 Parviz Owlia,3 Azar Sabokbar1 1Department of Microbiology, Karaj Branch, Islamic Azad University, Karaj, Iran; 2Department of Biology, Faculty of Basic Sciences, Shahed University, Tehran, Iran; 3Molecular Microbiology Research Center, Shahed University, Tehran, IranCorrespondence: Seyed Latif Mousavi Gargari Tel +989123118510Email slmousavi@shahed.ac.irBackground: Pseudomonas aeruginosa infection is the major cause of death in burn patients. Thus, in this study, a chimeric vaccine harboring the OprF185– 350–OprI22– 83–PcrV was designed and expressed in Escherichia coli. The immunogenicity of the recombinant chimer, OprI, OprF, and PcrV was studied in a burned mouse model.Methodology: Recombinant proteins including the proposed chimer, OprF, OprI, and PcrV were expressed in the E.coli. Mice were immunized with the purified recombinant proteins, and the antibody titre was estimated in the sera obtained from immunized mice. Immunized and control mice were challenged with 2, 5, and 10xLD50 of the P. aeruginosa strains (PAO1, PAK, and R5), and microbial counts were measured in the skin, liver, spleen, and kidney of the studied mice.Results: Results showed that the antibody titre (total IgG) was significantly increased by injection of 10 μg of chimeric protein in the experimental groups compared to the control groups. The antibody survival titre was high until 235 days after administration of the second booster. The survival rate of the mice infected with 10xLD50 was significantly increased and the number of bacteria was reduced, especially in the internal organs (kidney, spleen, and liver) compared to the mice immunized with any of the OprF, OprI, and PcrV proteins alone.Conclusion: The findings of our study revealed that the chimeric protein is a promising vaccine candidate for control of the P. aeruginosa infection.Keywords: burned, chimeric protein, Pseudomonas aeruginosa, vaccinehttps://www.dovepress.com/protective-efficacy-of-the-oprfopripcrv-recombinant-chimeric-protein-a-peer-reviewed-article-IDRburnedchimeric proteinpseudomonas aeruginosavaccine
collection DOAJ
language English
format Article
sources DOAJ
author Fakoor MH
Mousavi Gargari SL
Owlia P
Sabokbar A
spellingShingle Fakoor MH
Mousavi Gargari SL
Owlia P
Sabokbar A
Protective Efficacy of the OprF/OprI/PcrV Recombinant Chimeric Protein Against Pseudomonas aeruginosa in the Burned BALB/c Mouse Model
Infection and Drug Resistance
burned
chimeric protein
pseudomonas aeruginosa
vaccine
author_facet Fakoor MH
Mousavi Gargari SL
Owlia P
Sabokbar A
author_sort Fakoor MH
title Protective Efficacy of the OprF/OprI/PcrV Recombinant Chimeric Protein Against Pseudomonas aeruginosa in the Burned BALB/c Mouse Model
title_short Protective Efficacy of the OprF/OprI/PcrV Recombinant Chimeric Protein Against Pseudomonas aeruginosa in the Burned BALB/c Mouse Model
title_full Protective Efficacy of the OprF/OprI/PcrV Recombinant Chimeric Protein Against Pseudomonas aeruginosa in the Burned BALB/c Mouse Model
title_fullStr Protective Efficacy of the OprF/OprI/PcrV Recombinant Chimeric Protein Against Pseudomonas aeruginosa in the Burned BALB/c Mouse Model
title_full_unstemmed Protective Efficacy of the OprF/OprI/PcrV Recombinant Chimeric Protein Against Pseudomonas aeruginosa in the Burned BALB/c Mouse Model
title_sort protective efficacy of the oprf/opri/pcrv recombinant chimeric protein against pseudomonas aeruginosa in the burned balb/c mouse model
publisher Dove Medical Press
series Infection and Drug Resistance
issn 1178-6973
publishDate 2020-06-01
description Mohammad Hadi Fakoor,1 Seyed Latif Mousavi Gargari,2 Parviz Owlia,3 Azar Sabokbar1 1Department of Microbiology, Karaj Branch, Islamic Azad University, Karaj, Iran; 2Department of Biology, Faculty of Basic Sciences, Shahed University, Tehran, Iran; 3Molecular Microbiology Research Center, Shahed University, Tehran, IranCorrespondence: Seyed Latif Mousavi Gargari Tel +989123118510Email slmousavi@shahed.ac.irBackground: Pseudomonas aeruginosa infection is the major cause of death in burn patients. Thus, in this study, a chimeric vaccine harboring the OprF185– 350–OprI22– 83–PcrV was designed and expressed in Escherichia coli. The immunogenicity of the recombinant chimer, OprI, OprF, and PcrV was studied in a burned mouse model.Methodology: Recombinant proteins including the proposed chimer, OprF, OprI, and PcrV were expressed in the E.coli. Mice were immunized with the purified recombinant proteins, and the antibody titre was estimated in the sera obtained from immunized mice. Immunized and control mice were challenged with 2, 5, and 10xLD50 of the P. aeruginosa strains (PAO1, PAK, and R5), and microbial counts were measured in the skin, liver, spleen, and kidney of the studied mice.Results: Results showed that the antibody titre (total IgG) was significantly increased by injection of 10 μg of chimeric protein in the experimental groups compared to the control groups. The antibody survival titre was high until 235 days after administration of the second booster. The survival rate of the mice infected with 10xLD50 was significantly increased and the number of bacteria was reduced, especially in the internal organs (kidney, spleen, and liver) compared to the mice immunized with any of the OprF, OprI, and PcrV proteins alone.Conclusion: The findings of our study revealed that the chimeric protein is a promising vaccine candidate for control of the P. aeruginosa infection.Keywords: burned, chimeric protein, Pseudomonas aeruginosa, vaccine
topic burned
chimeric protein
pseudomonas aeruginosa
vaccine
url https://www.dovepress.com/protective-efficacy-of-the-oprfopripcrv-recombinant-chimeric-protein-a-peer-reviewed-article-IDR
work_keys_str_mv AT fakoormh protectiveefficacyoftheoprfopripcrvrecombinantchimericproteinagainstpseudomonasaeruginosaintheburnedbalbcmousemodel
AT mousavigargarisl protectiveefficacyoftheoprfopripcrvrecombinantchimericproteinagainstpseudomonasaeruginosaintheburnedbalbcmousemodel
AT owliap protectiveefficacyoftheoprfopripcrvrecombinantchimericproteinagainstpseudomonasaeruginosaintheburnedbalbcmousemodel
AT sabokbara protectiveefficacyoftheoprfopripcrvrecombinantchimericproteinagainstpseudomonasaeruginosaintheburnedbalbcmousemodel
_version_ 1724618661481676800